Corruption is the abuse of entrusted power for private gain and is embedded in health systems worldwide. This WHO report on the sustainable development goals cites a typology of the categories of health corruption and their characteristics that Deborah helped define for Transparency International.
The right to offer patients a choice to use the cheap, effective drug bevacizumab (Avastin) to treat wet age-related macular degeneration, has been a long time coming. In September 2018 – after just under a decade of being thwarted by judicial review and lobby – the NHS finally won the right to do so. It’s a situation Deborah has been investigating for many years.
When a junior doctor was convicted of manslaughter and struck off the medical register for her role in the death of six-year-old Jack Adcock, shockwaves reverberated through the medical profession.
Many doctors have argued that Dr Hadiza Bawa-Garba was unfairly punished for mistakes she made while working in an overstretched and under-resourced NHS. With access to full trial transcripts, witness statements and internal hospital inquiries, Panorama spoke to Dr Bawa-Garba and to the parents of Jack Adcock in order to tell the story in detail.
Doctors plan to prescribe bevacizumab (Avastin) despite legal threats from drug companies, and against GMC and NICE guidance. But is the GMC’s and the MHRA’s advice to doctors correct? Deborah investigated the latest in the debate around off-label use of bevacizumab https://www.bmj.com/content/359/bmj.j5016
Taxpayer-funded medical research is producing medicines which are increasingly unaffordable for patients who need them, says a new report by 5 live Investigates:
Deborah reported and researched a BBC investigation into add-on treatments for fertility. It found that nearly all costly add-on treatments offered by UK fertility clinics to increase the chance of a birth through IVF are not supported by high-quality evidence proving that they work http://www.bbc.co.uk/news/health-38094618